Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,695.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (0.15%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Trading Update

17 Nov 2021 07:00

RNS Number : 5915S
Spirax-Sarco Engineering PLC
17 November 2021
 

 

News Release

 

Wednesday 17th November 2021

TRADING UPDATE

Continued strong growth, guidance unchanged

 

Thermal energy management and niche pumping specialist, Spirax‐Sarco Engineering plc, issues the following trading update in respect of the four months ended 31st October 2021.

 

Economic environment

In the third quarter, global Industrial Production (IP) recovered from COVID-19 pandemic impacted levels in 2020, growing 4.9%. However, disruptions in the global supply chain leading to material shortages and rising costs resulted in a slight quarter-on-quarter sequential contraction of global IP. Full-year forecasts for 2021 have been revised down to 7.4%, compared to 8.6% forecasted at the time of our Half Year Results, while full-year 2022 forecasts have also been reduced to 4.3% from 5.0%.

 

Trading

We continue to experience very strong demand across the Group, with order books in all three businesses expanding in the four months to the end of October above our expectations at the time of the Half Year Results. Growth in orders was highest in Watson-Marlow, driven by continued COVID-19 vaccine related demand from its customers in the Pharmaceutical & Biotechnology sector. In Steam Specialties, demand growth was well ahead of IP growth and orders received year-to-date are above the comparative period in 2019. Demand for Electric Thermal Solutions has grown at an even faster rate than Steam Specialties, after adjusting for the US Navy order secured in 2020, the largest single order in our Group's history.

 

Although we have a diversified and resilient supply chain, we are not immune to current disruptions being experienced globally and across all sectors. While all three businesses were somewhat impacted by shipment delays, the effects have been greater within Watson-Marlow and Electric Thermal Solutions. Within Electric Thermal Solutions we also experienced delays in the delivery of operational performance improvements resulting in lower sales growth than anticipated. The adverse effect of rising material and freight costs continues to be broadly offset by internal efficiencies and price management practices.

 

Currency effects had an adverse impact on sales and operating profit, compared to the same period of 2020, as sterling strengthened against our basket of trade currencies. If current exchange rates were to prevail for the remainder of the year, we anticipate close to 4% adverse impact on full year sales and profit, compared with the full year 2020.

 

Financial position

Our business remains highly cash generative and we maintain a strong balance sheet. Excluding leases, our net borrowings at 31st October 2021 were £131 million, down from £193 million at 30th June 2021. The interim dividend of 38.5p per share was paid on 12th November 2021 with a cash impact of £28 million.

 

 

Outlook

We are maintaining our overall guidance despite the supply chain challenges in the second half of the year and expect record levels of revenue, profit and operating margin for the full year 2021.

 

As anticipated, forecasted global IP growth for 2021 has continued to be revised downward since our Half Year Results, partly reflecting the impact of disruption to the global supply chain, with further risk of a slowing IP growth rate in the fourth quarter and into next year. Despite these challenges, we expect to end the year with a record order book across all three businesses.

 

For 2022, we expect growth in both sales and profit, underpinned by continuing strong demand and our higher-than-normal order book. The Group operating margin is expected to be lower due to the full year impact of revenue investments in 2021, as well as further investment planned in 2022 to support our future growth and operating margins.

 

Spirax-Sarco Engineering plc expects to publish its preliminary 2021 results on 10th March 2022.

 

Enquiries:

Nimesh Patel, Chief Financial Officer

Shaun Laubscher, Head of Investor Relations

Tel: 01242 535234

 

Note: Operating profit refers to adjusted operating profit and organic performance measures are expressed at constant currency, excluding contributions from acquisitions and disposals, as explained in Note 2 to the Consolidated Financial Statements for the period ended 31st December 2020.

 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow Fluid Technology Group provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs over 8,400 people, of whom close to 2,000 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

Further information can be found at www.spiraxsarcoengineering.com

 RNS filter: Inside information prior to release

 

LEI 213800WFVZQMHOZP2W17

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFMFWMEFSESF
Date   Source Headline
8th Jun 20261:24 pmRNSDirector/PDMR Shareholding
1st Jun 202610:28 amRNSChange in Major Shareholding
29th May 20262:24 pmRNSUpdate on Directorships held by Company Directors
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20265:24 pmRNSDirector/PDMR Shareholding
19th May 20269:16 amRNSChange in Major Shareholding
14th May 20262:47 pmRNSExternal Directorships held by Company Directors
14th May 202610:39 amRNSDirector/PDMR Shareholding
13th May 20264:12 pmRNSResult of AGM
13th May 20267:00 amRNSTrading Update
8th May 20263:42 pmRNSChange in Major Shareholding
7th May 20269:03 amRNSDirector/PDMR Shareholding
8th Apr 20262:22 pmRNSDirector/PDMR Shareholding
8th Apr 20269:30 amRNSAnnual Report and Accounts 2025 and Notice of AGM
18th Mar 20264:53 pmRNSDirector/PDMR Shareholding
11th Mar 20261:53 pmRNSTotal Voting Rights
10th Mar 20265:01 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 Full Year Results
10th Mar 20267:00 amRNS2025 Full Year Results
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
10th Feb 20269:30 amRNSChange in Director Details
6th Feb 20263:47 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:50 pmRNSChange in Director Details
30th Jan 20262:19 pmRNSHolding(s) in Company
6th Jan 20263:10 pmRNSDirector/PDMR Shareholding
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 202510:34 amRNSBlocklisting Application
9th Dec 20252:35 pmRNSDirector/PDMR Shareholding
18th Nov 20259:40 amRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTrading Update
7th Nov 20251:56 pmRNSDirector/PDMR Shareholding
5th Nov 20258:39 amRNSHolding(s) in Company
22nd Oct 20257:00 amRNSBoard Appointment
7th Oct 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSDirector/PDMR Shareholding
1st Sep 20259:35 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSBoard Committee Membership Update
12th Aug 20257:00 amRNS2025 Half Year Results
7th Aug 20257:00 amRNSDirector/PDMR Shareholding
24th Jul 20254:58 pmRNSDirector/PDMR Shareholding
9th Jul 20254:26 pmRNSDirector/PDMR Shareholding
13th Jun 20253:36 pmRNSDirector/PDMR Shareholding
14th May 20254:48 pmRNSResult of AGM
14th May 20257:00 amRNSTrading Update
8th May 202511:03 amRNSDirector/PDMR Shareholding
23rd Apr 20255:13 pmRNSChange in Director Details
22nd Apr 20253:52 pmRNSDirector/PDMR Shareholding
11th Apr 20255:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.